This topic keeps coming up. I hear about it during the planning stages of
clinical trials, from fellow ID clinicians who want to avoid broad spectrum
empiric therapy or to de-escalate from such quickly in order to reduce
resistance, and, occasionally, from small companies peddling rapid diagnostics.
The Infectious Diseases Society and FDA held a workshop on the topic a few
years ago. We heard about nucleic acid
based approaches, rapid serology, rapid this and that. There were three key problems that were
raised. First, the regulatory path in
the US is anything but straightforward – especially if you wanted to link a
diagnostic with an antibiotic (but why would we do that?). Second, industry is
not interested (at least in the US) because (a) the regulatory hurdles are high
and (b) they are skeptical that they would ever make a return on their
investment (the situation is different in Europe where the regulatory approach
to diagnostics is easier and therefore so is the return on investment). But,
most importantly, at least to me, rapid diagnostics are not rapid – far from it
– again – especially in the US. What am
I talking about? FDA requirements?
Technological barriers? Nope.
I’m talking about the rope a dope
system currently in place in US hospital laboratories and on hospital wards in
the US. To understand this, you have to take a trip with me down memory
lane. When I was training as a medical
student at the county hospital in Cleveland, we were expected to have done all
the appropriate diagnostic tests ourselves on the patient to rule out or in the
most likely diagnoses on our list of differential diagnoses by the morning
after admission. That meant – all
appropriate specimens collected, Gram stains performed and read and cultures
plated – by us! We even had to collect
and stain bone marrow specimens if the patient had new anemia. The infectious diseases service would come by
in the afternoon the next day and review our Gram stains with us. They would also check our culture plates
(which had been incubating in an incubator adjacent to the ward) overnight and
they would point out colonies and help interpret the cultures immediately. Of course, those were the days when infectious
diseases fellows were expected to be able to read Gram stains and interpret
growing cultures of microorganisms from patient specimens.
Those days, unfortunately in my
view, are long gone. Law suits and the
federal government have seen to that. The Clinical Laboratory Improvement
Amendments (CLIA) law was passed in 1988. Under this law, only certified
laboratories and laboratorians are allowed to report clinical laboratory
results in the US. This law was
supported by hospitals desiring to limit lawsuits, but laboratory workers
trying to protect their jobs and by patient advocates thinking that this would
mean better care. This meant that our county hospital in Cleveland had to
remove all the laboratories they had carefully constructed adjacent to each
patient ward. Physicians could still see
Gram stains and cultures, but only if they did so in the official clinical
laboratory – and their interpretations could not become part of the patient
record. Logistically, what does this mean?
A specimen is collected from the patient by the physician, nurse or
technician, and is placed in an outbox on the ward. The specimen then has to be
transported to a laboratory – which may or may not be on site in the same
hospital where the patient is located. On
arrival in the laboratory, the specimen is labeled and entered into some
tracking system by someone – then, eventually, is processed. Is the lab open 7/7 24/24? Most are not. When I was training – I (or
someone) was definitely available 7/7 and 24/24. Once the specimen is processed
– if there is a rapid test available in the laboratory – that test could be
performed and the results reported to the caregiver. But you get the idea. Even the most rapid of tests that can be
completed within say 3 hours usually take at a minimum 8 hours and, overnight –
12 hours and, over a weekend – who knows how long?
So our biggest challenge is
ourselves! Our hospital bureaucracy, the
laboratory workers and
many healthcare advocates are all conspiring to make
rapid diagnostics logistically less useful than they might be. Imagine if a machine was available on the
ward and that there was a designated nurse trained to use the machine available
(and with time) to operate such a machine during each nursing shift. What a difference
that would make. When will we get there?
We have already gotten there for an office-based test to detect strep throat –
waived for CLIA requirements. What about
for hospital-based tests? You tell me!
Back when I worked in the IVD industry during the 70s and 80s, most hospitals had STAT labs. I'm not sure if CLIA did away with these, but it does seem that larger hospitals offer around the clock testing for many analytes. Is it really as bad as you indicate?
ReplyDeleteThanks for your comment. There are STAT labs still - but generally not for microbiology. The STAT labs that do exist are CLIA compliant anyway. So - yeah - it is. Sorry.
ReplyDelete